Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study
Inflammatory Bowel Diseases · 2024
DOI: 10.1093/ibd/izad162 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Aakash Desai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA. Hauptthemen laut MEDLINE: COVID-19, Herpes Zoster, Inflammatory Bowel Diseases, Propensity Score. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Background
There is evidence that SARS-CoV2 infection can increase the risk of herpes zoster (HZ) in the general population. However, the risk in patients with inflammatory bowel disease (IBD) is not known.
Methods
The TriNetX database was utilized to conduct a retrospective cohort study in patients with IBD after SARS-CoV2 infection and patients without a SARS-CoV2 infection (IBD control cohort). The primary outcome was to evaluate the risk of HZ between the 2 cohorts. One-to-one (1:1) propensity score matching was performed for demographic parameters, HZ risk factors and IBD medications between the 2 cohorts. Adjusted odds ratio (aOR) with 95% confidence interval (CI) were calculated.
Results
After propensity score matching, patients with IBD with a SARS-CoV2 infection were at an increased risk for HZ (aOR, 2.16; 95% CI, 1.53-3.04) compared with IBD control cohort in the pre-COVID-19 vaccine era. There was no difference in the risk (aOR, 0.87; 95% CI, 0.44-1.75) of a composite outcome of HZ complications (hospitalization, post-herpetic neuralgia, and neurologic complications) between the 2 cohorts. The IBD SARS-CoV2 cohort was also at an increased risk for HZ (aOR, 3.04; 95% CI, 1.48-6.24) compared with IBD control cohort in the postvaccine era. However, the risk of HZ in the postvaccine era was decreased (aOR, 0.45; 95% CI, 0.27-0.76) compared with IBD SARS-CoV2 cohort in the prevaccine era.
Conclusions
Our study showed that SARS-CoV2 infection is associated with an increased risk of HZ in patients with IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.
- Department of Internal Medicine, Saint Vincent Hospital, Worchester, MA, USA.
- School of Pharmacy, University of Wisconsin School of Medicine & Public Health, Madison, WI, USA.
- Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
- American University of Beirut, Beirut, Lebanon.
- Division of Gastroenterology & Hepatology, Allegheny Health Network, Pittsburgh, PA, USA.
ORCID-Profile: Aakash Desai, Jana G Hashash, Freddy Caldera
Zitieren
APA
Desai, A., Soni, A., Hayney, M. S., Hashash, J. G., Kochhar, G. S., Farraye, F. A., & Caldera, F. (2024). Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad162
Vancouver
Desai A, Soni A, Hayney MS, Hashash JG, Kochhar GS, Farraye FA, et al. Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad162
BibTeX
@article{Desai2024,
author = {Desai, Aakash and Soni, Aakriti and Hayney, Mary S and Hashash, Jana G and Kochhar, Gursimran S and Farraye, Francis A and Caldera, Freddy},
title = {Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study},
journal = {Inflammatory Bowel Diseases},
year = {2024},
doi = {10.1093/ibd/izad162}
}
EUVIMED